Please login to the form below

Not currently logged in
Email:
Password:

Zoladex

This page shows the latest Zoladex news and features for those working in and with pharma, biotech and healthcare.

After MYSTIC setback, FDA gives some comfort to AZ

After MYSTIC setback, FDA gives some comfort to AZ

expansion of a facility in Macclesfield intended to support high demand for prostate cancer drug Zoladex.

Latest news

  • Grünenthal buys Zomig rights as AZ slimming drive continues Grünenthal buys Zomig rights as AZ slimming drive continues

    This work has seen it agree deals with TerSera Therapeutics ($320m for Zoladex), ProStakan ($70m for Moventig), Aspen ($770m for seven anaesthetics drugs) and, most recently, Recordati ($300m for two blood

  • AZ agrees to $320m deal for Zoladex AZ agrees to $320m deal for Zoladex

    AZ agrees to $320m deal for Zoladex. TerSera Therapeutics acquires rights to oncology drug in US and Canada. ... ongoing. A further $70m is also up for grabs should Zoladex (goserelin acetate implant) meet a series of sales-related milestones.

  • Roche maintains dominance as leading cancer drugmaker Roche maintains dominance as leading cancer drugmaker

    AZ saw sales fall across much of its oncology brands, with a 4% decline for its biggest cancer seller Zoladex (goserelin) for certain breast cancers with revenue just shy of being

  • AZ invests £120m in UK cancer drug production AZ invests £120m in UK cancer drug production

    AZ invests £120m in UK cancer drug production. New facility in Macclesfield to manufacture Zoladex will retain 300 jobs. ... The new building in Macclesfield, Cheshire will focus on the production of prostate cancer treatment Zoladex (gosrelin), which

  • This month in 1901: Birth of Charles Brenton Huggins

    Such drugs include Merck &Co's Drogenil (flutamide), Takeda's Prostap (leuprorelin) and Casodex (bicalutamide) and Zoladex (goserelin), both of which are made by AstraZeneca.

More from news
Approximately 2 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2017 Deal Watch February 2017

    First approved in North America in 1989, Zoladex sales in 2016 were $69m in the US and Canada and $816m globally. ... Licence. 358. AstraZeneca/ TerSera Therapeutics. Zoladex, goserelin acetate implant for prostate, breast cancer, benign gynaecological

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics